| Glycosaminoglycan derived
disaccharides |
| |
| Heparin/Heparan Series |
| |
|
| |
|
|
DUA-2S®GlcNS-6S
Na4(disaccharide I-S) |
|
| |
|
| Predominant disaccharide produced from
heparin by heparinases I and II. |
| C12H15NO19S3Na4
- FW 665.37 |
1mg 5mg 25mg
| |
| | |
|
|
DUA®GlcNS-6S
Na3(disaccharide II-S) |
|
| |
|
| Produced from heparinase II digestion of
heparin and heparan sulphate. |
| C12H16NO16S2Na3
- FW 563.34 |
0.5mg 2mg
| |
| | |
|
|
DUA-2S®GlcNS
Na3(disaccharide III-S) |
|
| |
|
| Produced from heparin by digestion with
heparinases I and II. |
| C12H16NO16S2Na3
- FW 563.34 |
1mg 2mg 5mg
| |
| | |
|
|
DUA®GlcNS
Na2(disaccharide IV-S) |
|
| |
|
| Produced from heparin sulphate by
digestion with heparinase III. |
| C12H17NO13SNa2
- FW 461.30 |
1mg 2mg | |
| | |
|
|
DUA-2S®GlcNAc-6S
Na3(disaccharide I-A) |
|
| |
|
| Minor component produced from heparin by
heparinase II. |
| C14H18NO17S2Na3
- FW 605.38 |
1mg 2mg 5mg
| |
| | |
|
|
DUA®GlcNAc-6S
Na2(disaccharide II-A) |
|
| |
|
| Product of the action of heparinases II
and III on heparin and heparan
sulphate. |
| C14H19NO14SNa2
- FW 503.34 |
1mg 5mg | |
| | |
|
|
DUA-2S®GlcNAc
Na2(disaccharide III-A) |
|
| |
|
| Minor product of the action of heparinase
II on heparin. |
| C14H19NO14SNa2
- FW 503.34 |
1mg 5mg | |
| | |
|
|
DUA®GlcNAc Na
(disaccharide IV-A) |
|
| |
|
| Produced from heparan sulphate by
digestion with heparinase III. |
| C14H20NO11Na - FW
401.30 |
0.5mg 5mg
| |
| | |
| Chondroitin Series |
| |
|
| |
|
|
DUA®GalNAc Na
(disaccharide D Di-OS)
|
|
| |
|
| Produced from various chondroitin
sulphates by the action of chondroitinases ABC, AC-1 and
C. |
| C14H20NO11Na - FW
401.30 |
5mg 10mg | |
| | |
|
|
DUA®GalNAc-4S
Na2(disaccharide DDi-4S)
|
|
| |
|
| Produced from various chondroitin
sulphates by the action of chondroitinases ABC, B and
AC-1. |
| C14H19NO14SNa2
- FW 503.34 |
5mg 10mg | |
| | |
|
|
DUA®GalNAc-6S
Na2 (disaccharide D
Di-6S) |
|
| |
|
| Produced from various chondroitin
sulphates by the action of chondroitinases ABC, AC-1 and
C. |
| C14H19NO14SNa2
- FW 503.34 |
5mg 10mg | |
| | |
|
|
DUA®GalNAc-4S, 6S
Na3(disaccharide D
Di-disE) |
|
| |
|
| Produced from various chondroitin
sulphates by the action of chondroitinases ABC, B and/or
AC-1. |
| C14H18NO17S2Na3
- FW 605.38 |
1mg 5mg | |
| | |
|
|
DUA-2S®GalNAc-4S
Na3 (disaccharide D
Di-disB) |
|
| |
|
| Produced from various chondroitin
sulphates by action of chondroitinase ABC and/or B. Most
typically from chondroitin sulphate B (dermatan
sulphate). |
| C14H18NO17S2Na3
- FW 605.38 |
1mg 5mg | |
| | |
|
|
DUA-2S®GalNAc-6S
Na3 (disaccharide D
Di-disD) |
|
| |
|
| Produced from various chondroitin
sulphates by action of chondroitinase
ABC. |
| C14H18NO17S2Na3
- FW 605.38 |
1mg 5mg | |
| | |
|
|
DUA-2S®GalNAc-4S-6S Na4(disaccharide
D Di-triS)
|
|
| |
|
| Produced as a minor component by the
action of chondroitinase ABC on various chondroitin sulphates,
particularly B. |
| C14H17NO20S3Na4
- FW 707.42 |
1mg 5mg | |
| | |
|
|
DUA-2S®GalNAc
Na2(disaccharide D
Di-UA2S) |
|
| |
|
| Produced as a minor component from various
chondroitin sulphates by the action of chondroitinase
ABC. |
| C14H19NO14SNa2
- FW 503.34 |
1mg 5mg | |
| | |
| Hyaluronic Acid Series |
| |
|
| |
|
|
DUA®GlcNAc Na
(disaccharide D Di-HA)
|
|
| |
|
| The only unsaturated disaccharide produced
from hyaluronic acid by the action of chondroitinases ABC or
AC-1. |
| C14H20NO11Na - FW
401.30 |
2mg 5mg | |
| | |
| Chondroitin Saturated
Series |
| |
|
| |
|
|
GlcA®GalNAc-4S Na2(disaccharide
Di-4S) |
|
| |
|
| The disaccharide repeat of chondroitin
sulphate A (chondroitin 4-sulphate). |
| C14H21NO15SNa12
- FW 521.36 |
1mg 2mg | |
| | |
|
|
GlcA®GalNAc-6S Na2(disaccharide
Di-6S) |
|
| |
|
| The disaccharide repeat of chondroitin
sulphate C (chondroitin 6-sulphate). |
| C14H21NO15SNa2
- FW 521.36 |
1mg 2mg | |
| | |